| Literature DB >> 35415032 |
Takayuki Tachibana1, Naoto Mouri2, Chiaki Sano3, Ryuichi Ohta4.
Abstract
Klebsiella ozaenae, a subtype of K. pneumonia, causes chronic upper respiratory tract infections, such as rhinitis and rhinoscleroma, and can also cause lethal infections. We report the case of a patient who developed pneumonia caused by K. ozaenae. An 87-year-old man presented to our hospital with fever and chills. Physical examination revealed no findings other than bilateral crackles in the lower lung fields. Chest computed tomography (CT) showed infiltrative shadows in the lower left lung field. Moreover, K. ozaenae was detected in blood cultures. Based on the examination results, including radiography and blood culture, the patient was diagnosed with pneumonia caused by K. ozaenae. On admission, the patient was treated with intravenous ceftriaxone (CTRX), but he did not recover. After determining the antibiotic susceptibility of K. ozaenae, we stopped administering CTRX and started ampicillin/sulbactam (ABPC/SBT) treatment for two weeks. During the ABPC/SBT administration, a second chest CT showed a new infiltrative shadow in the upper left lung field. Despite these findings, the patient was discharged from the hospital as his vital signs were stable and his general condition was good. After two weeks of ABPC/SBT treatment, the patient was switched to minocycline and followed up. Although infections caused by K. ozaenae are rare, they can be life-threatening. K. ozaenae identification in a patient's blood culture indicates a potentially impaired immune system, prompting physicians to evaluate the patient's immune system.Entities:
Keywords: antibiotic resistance; bacteremia; general medicine; immunocompromised; klebsiella; pneumonia; rural hospital
Year: 2022 PMID: 35415032 PMCID: PMC8993129 DOI: 10.7759/cureus.23001
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Laboratory findings on admission.
| Laboratory parameter | Day 1 | Reference range |
| White blood cell (×103/μL) | 8.4 | 3.5–9.1 |
| Red blood cell (×106/μL) | 4.03 | 3.76–5.50 |
| Hemoglobin (g/dL) | 13.2 | 11.3–15.2 |
| Hematocrit (%) | 39 | 33.4–44.9 |
| Mean corpuscular volume (fL) | 96.8 | 79.0–100.0 |
| Platelet (×104/μL) | 13.1 | 13.0–36.9 |
| Neutrophil (%) | 79 | 44.0–72.0 |
| Lymphocyte (%) | 12 | 18.0–59.0 |
| Monocyte (%) | 8.8 | 0.0–12.0 |
| Eosinophil (%) | 0 | 0.0–10.0 |
| Basophil (%) | 0.2 | 0.0–3.0 |
| Aspartate aminotransferase (U/L) | 25 | 8–38 |
| Alanine aminotransferase (U/L) | 18 | 4–43 |
| Alkaline phosphatase (U/L) | 127 | 106–322 |
| Gamma-glutamyl transpeptidase (U/L) | 25 | 0–48 |
| Lactate dehydrogenase (U/L) | 222 | 121–245 |
| Total protein (g/dL) | 7.8 | 6.5–8.3 |
| Albumin (g/dL) | 39 | 3.8–5.3 |
| Blood sugar (mg/dL) | 128 | 60–109 |
| Blood urea nitrogen (mg/dL) | 25.6 | 8–20 |
| Creatinine (mg/dL) | 1.62 | 0.40–1.10 |
| Serum Na (mEq/L) | 133 | 135–150 |
| Serum K (mEq/L) | 4 | 3.5–5.3 |
| Serum Cl (mEq/L) | 93 | 98–110 |
| Estimated glomerular filtration rate (mL/minute/1.73 m2) | 31.7 | <60.0 |
Figure 1Initial chest computed tomography scan showing opacity in the left lower lung zone at admission.
Antimicrobial susceptibility of Klebsiella ozaenae and Klebsiella aerogenes.
MIC: minimal inhibitory concentration; R: resistant; I: intermediate; S: susceptible
| Antimicrobial agents |
|
| MIC (μg/mL) |
| Ampicillin | I | R | 16 |
| Piperacillin | S | S | ≤16 |
| Cefazolin | S | R | ≤2 |
| Cefotiam | I | R | 16 |
| Ceftriaxone | R | R | >2 |
| Ceftazidime | R | S | >16 |
| Cefepime | R | S | <16 |
| Cefaclor | S | R | ≤8 |
| Cefmetazole | R | R | >32 |
| Latamoxef | S | >8 | |
| Imipenem | S | S | ≤1 |
| Meropenem | S | S | ≤1 |
| Doripenem | S | S | ≤1 |
| Aztreonam | R | S | >16 |
| Sulbactam/ampicillin | S | S | ≤8 |
| Tazobactam/piperacillin | S | S | |
| Gentamicin | S | S | |
| Tobramycin | S | S | |
| Amikacin | S | S | |
| Levofloxacin | S | S | |
| Ciprofloxacin | S | S | |
| Sulfamethoxazole- trimethoprim | S | S | |
| Fosfomycin | R | I | |
| Colistin | R |
Figure 2Second chest computed tomography scan revealing that opacity in the lower left lung lobe had improved but a new opacity had appeared in the left upper lung lobe.
Figure 3Clinical course of the case.